Zobrazeno 1 - 10
of 591
pro vyhledávání: '"F. Brun-Vézinet"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jacques Izopet, Jacqueline Cottalorda, Vincent Calvez, Charlotte Charpentier, Henia Saoudin, Georges Dos Santos, Mary-Anne Trabaud, Francis Barin, V. Calvez, Cécile Henquell, Delphine Desbois, C. Delaugerre, Slim Fourati, D. Bettinger, Thomas Bourlet, Anne Krivine, Bernard Masquelier, S. Vallet, M. Bouvier-Alias, Catherine Tamalet, B. Masquelier, S. Rogez, Coralie Pallier, J. C. Plantier, C. Charpentier, F. Barin, J. Cottalorda, A. Maillard, Alexandre Storto, G. DosSantos, Chakib Alloui, B. Montes, Marie-Laure Chaix, A. G. Marcelin, Anne Signori-Schmuck, D. Desbois, Anne-Geneviève Marcelin, Marie Laure Chaix, C. Tamalet, F. Brun-Vézinet, Françoise Brun-Vézinet, J. Izopet, Philippe Flandre, G. Anies, Anne Maillard, Diane Descamps, Patrice Andre, Jean-Claude Tardy, Dominique Costagliola, Brigitte Montes, Laurence Morand-Joubert, Annick Ruffault, Jean-Christophe Plantier, Sophie Pakianather, L. Morand-Joubert, Constance Delaugerre
Publikováno v:
Journal of Antimicrobial Chemotherapy. 65:2620-2627
Objectives: To estimate the prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-1-infected patients in France. Methods: Resistance mutations were sought in samples from 530 newly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0281a34a877227a1687b3f7e4d2b1
https://doi.org/10.1093/jac/dkq380
https://doi.org/10.1093/jac/dkq380
Autor:
F. Brun-Vézinet, C. Charpentier
Publikováno v:
Medecine et maladies infectieuses. 43(5)
At the end of 2011, UNAIDS estimated that 34 million (31.4 to 35.9) individuals were infected by HIV worldwide and that 2.5 million were newly infected during the year. Since 2001, we have observed an increased number of HIV-infected patients in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afea90cc2891293cd88691acea005a48
https://pubmed.ncbi.nlm.nih.gov/23628423
https://pubmed.ncbi.nlm.nih.gov/23628423
Autor:
A, Depatureaux, M, Leoz, F, De Oliveira, M, Gueudin, F, Damond, D, Descamps, F, Brun-Vézinet, V, Lemée, F, Simon, F, Barin, J-C, Plantier
Publikováno v:
Medecine et maladies infectieuses. 40(12)
HIV-1 group O (HIV-O), mainly found in Cameroon, has a very high genetic diversity with consequences on the diagnosis and treatment of patients, requiring the development of specific tools.We present the currently available tools for the specific det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1c3d072ad14dc7d4cee1e1537eb5aa2
https://pubmed.ncbi.nlm.nih.gov/20646884
https://pubmed.ncbi.nlm.nih.gov/20646884
Publikováno v:
Pathologie-biologie. 57(2)
Human immunodeficiency viruses HIV-1 and HIV-2 are the results of multi-interspecies transmissions from simian virus to humans. HIV-1 viruses are very divergent and are classified in three groups: M, N and O. The group M is subdivided in nine subtype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9701019b1b7ef199b4b683663f074dcb
https://pubmed.ncbi.nlm.nih.gov/18511216
https://pubmed.ncbi.nlm.nih.gov/18511216
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 24(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f31c5195b29ab75a8e94969f83bfcb19
https://pubmed.ncbi.nlm.nih.gov/10877502
https://pubmed.ncbi.nlm.nih.gov/10877502
Autor:
E, Couturier, F, Damond, P, Roques, H, Fleury, F, Barin, J B, Brunet, F, Brun-Vézinet, F, Simon
Publikováno v:
AIDS (London, England). 14(3)
To study the distribution of HIV-1 subtypes in France and to describe the characteristics of patients infected with non-B subtypes.All adults who tested HIV-1 positive on Western blot for the first time in one of the participating laboratories betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d57c772153f6df27947a6c90e9df0c0e
https://pubmed.ncbi.nlm.nih.gov/10716505
https://pubmed.ncbi.nlm.nih.gov/10716505
Autor:
D, Descamps, P, Flandre, V, Calvez, G, Peytavin, V, Meiffredy, G, Collin, C, Delaugerre, S, Robert-Delmas, B, Bazin, J P, Aboulker, G, Pialoux, F, Raffi, F, Brun-Vézinet
Publikováno v:
JAMA. 283(2)
In the Trilège trial, following induction with a zidovudine, lamivudine, and indinavir regimen, human immunodeficiency virus (HIV) replication was less suppressed by 2-drug maintenance therapy than by triple-drug therapy.To identify mechanisms of vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0612147d7cb0519dc7bfb059b2b16067
https://pubmed.ncbi.nlm.nih.gov/10634342
https://pubmed.ncbi.nlm.nih.gov/10634342
Publikováno v:
Bulletin de la Societe de pathologie exotique (1990). 92(4)
The variability of human immunodeficiency virus type 1 (HIV-1) is very high. To date, three distinct lineages of HIVs, type 1 group M, type 1 group O and type 2 are described, suggesting at least three different zoonotic infections. HIV-1 group M is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::814cb043e5ac008f9edd912b41fdf96c
https://pubmed.ncbi.nlm.nih.gov/10572662
https://pubmed.ncbi.nlm.nih.gov/10572662